About NudC domain-containing protein 3
NudC domain-containing protein 3 (NUDCD3) is a protein
from Homo sapiens identified by UniProt accession
Q8IVD9, 361 residues long.
MolForge cross-references it against 0 known binders and
50 disease associations.
Target properties
| Protein name | NudC domain-containing protein 3 |
| UniProt accession | Q8IVD9 |
| Gene | NUDCD3 |
| Organism | Homo sapiens |
| Length | 361 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (50)
Diseases linked to this target (Open Targets).
- self reported educational attainment · score 0.18
- neurodegenerative disease · score 0.18
- hyperinsulinism due to INSR deficiency · score 0.06
- hyperinsulinism-hyperammonemia syndrome · score 0.06
- low density lipoprotein cholesterol measurement · score 0.05
- hyperinsulinism due to glucokinase deficiency · score 0.05
- MODY · score 0.05
- exercise-induced hyperinsulinism · score 0.04
- diabetes mellitus, permanent neonatal 4 · score 0.04
- diabetes mellitus, transient neonatal, 3 · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8IVD9-F1 | alphafold | PREDICTED | 79.46 | — |
Amino-acid sequence (361 residues)
METGAAELYD QALLGILQHV GNVQDFLRVL FGFLYRKTDF YRLLRHPSDR MGFPPGAAQA LVLQVFKTFD HMARQDDEKR RQELEEKIRR KEEEEAKTVS AAAAEKEPVP VPVQEIEIDS TTELDGHQEV EKVQPPGPVK EMAHGSQEAE APGAVAGAAE VPREPPILPR IQEQFQKNPD SYNGAVRENY TWSQDYTDLE VRVPVPKHVV KGKQVSVALS SSSIRVAMLE ENGERVLMEG KLTHKINTES SLWSLEPGKC VLVNLSKVGE YWWNAILEGE EPIDIDKINK ERSMATVDEE EQAVLDRLTF DYHQKLQGKP QSHELKVHEM LKKGWDAEGS PFRGQRFDPA MFNISPGAVQ F
Explore NudC domain-containing protein 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets